Viral Biosafety Level – 3 

Indian Institute of Science
Bengaluru, India

------ FACILITY OVERVIEW

A dedicated facility for advanced viral research

The Viral Biosafety Level-3 (BSL-3) facility has been established in the Centre for Infectious Disease Research (CIDR) Building, IISc Campus, Bengaluru, for conducting research on BSL-3 category viral pathogens such as SARS-CoV-2.

The facility includes a BSL-3 laboratory for cell-based experiments and an infection-cum-necropsy room for animal experiments, along with appropriate change rooms, an autoclave room, and a plant room.

The laboratory incorporates specialized safety and engineering features to maintain the required negative-pressure environment and unidirectional airflow for laboratory personnel safety. Users should review the applicable SOPs and access requirements before requesting facility use.

Consultancy & Collaborative Research

The Viral BSL-3 facility undertakes consultancy research projects related to vaccine and antiviral studies.

Contact:
shashankt@iisc.ac.in

01
Standard Operating Procedures
01
Guidelines and Fee Structure
01
User Request Form
01
Medical Sheet for user
01
Viral BSL-3 Booking

------- INFRASTRUCTURE

Inside the Viral BSL-3 facility

Dedicated containment laboratories, controlled-access workspaces and specialized equipment support safe experimental workflows across cell based and animal studies.

------- RESEARCH PORTFOLIO

Vaccine Studies

 

CIDR’s Viral BSL-3 facility supports collaborative evaluation of vaccine candidates against SARS-CoV-2, including mRNA, glycoconjugate, virus-like particle, subunit and liposomal vaccine platforms.

VACCINE STUDY

Gennova Biopharmaceuticals Ltd., India

Evaluating efficacy of an mRNA-based COVID-19 vaccine candidate (GEMCOVAC-19).
VACCINE STUDY

Glycovax Pharma, Canada

Evaluating efficacy of a glycoconjugate vaccine candidate against SARS-CoV-2.
VACCINE STUDY

Premas Biotech Pvt. Ltd., India

Evaluating efficacy of a virus-like particle vaccine candidate against SARS-CoV-2.
VACCINE STUDY

CSIR-IMTECH, India

Testing efficacy of a subunit vaccine against SARS-CoV-2.
VACCINE STUDY

CSIR-CCMB, Hyderabad

Evaluating efficacy of an mRNA-based COVID-19 vaccine candidate.
VACCINE STUDY

Bhabha Atomic Research Centre, Mumbai

Evaluating efficacy of a liposomal Spike vaccine candidate against SARS-CoV-2.

------- RESEARCH PORTFOLIO

Antiviral Studies

 

The facility also supports antiviral efficacy studies, cell-culture based testing, environmental decontamination evaluation and preclinical investigations.

ANTIVIRAL STUDY

CSIR-CIMAP, India

Testing anti-SARS-CoV-2 activity of different herbal formulations through oral administration.
ANTIVIRAL STUDY

Sharp Business Systems, India

Testing in-vitro anti-SARS-CoV-2 activity of tungsten trioxide-coated plates and Naturizer solution.
ANTIVIRAL STUDY

Kashiv Biosciences, USA

Testing in-vitro antiviral efficacy of synthetic chemical entities against SARS-CoV-2 in cell culture.
ANTIVIRAL STUDY

Biomoneta Research Pvt. Ltd., India

Evaluating the efficacy of ZeBox in eliminating airborne influenza and SARS-CoV-2 viruses.
Antiviral Studies

GeNext Genomics Pvt. Ltd.

Evaluating efficacy of anti-SARS-CoV-2 ScFVs in a Spike-pseudotyped entry assay.

------- CAPABILITIES

Services Provided

 

The facility supports a range of virology, immunology, histology and preclinical research workflows for academic and collaborative studies.

Services Provided

RT-PCR Related Assays

SARS-CoV-2 viral load and pro- and anti-inflammatory cytokine levels.
Services Provided

ELISA-Based Assays

SARS-CoV-2 RBD-specific antibodies and cytokine levels.
Services Provided

Histology Studies

Studies involving lungs, spleen, liver, nasal turbinates and related tissues.
Services Provided

Neutralization Assays

Live-virus and pseudovirus-based neutralization assays.
Services Provided

Small-Animal Studies

Mice and hamster studies to monitor body weight, clinical signs and organ morphology.
Services Provided

Cytotoxicity & Antiviral Assays

Cell-based assays across multiple cell lines and organoid models.

------- Facility Contacts

Viral BSL-3 Laboratory

 

Faculty In-Charge

Dr. Shashank Tripathi
Viral Biosafety Level-3 Laboratory
Centre for Infectious Disease Research (CIDR)
MCB Department, Indian Institute of Science

shashankt@iisc.ac.in

In-Charge

Dr. Rohan Narayan
Viral Biosafety Level-3 Laboratory
Centre for Infectious Disease Research (CIDR)
MCB Department, Indian Institute of Science